Global Dividend Yield vs Price To Sales Ratio Analysis

GMRE Stock

USD 7.97 0.15 1.85%

Global Medical financial indicator trend analysis is much more than just examining Global Medical REIT latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Global Medical REIT is a good investment. Please check the relationship between Global Medical Dividend Yield and its Price To Sales Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Dividend Yield vs Price To Sales Ratio

Dividend Yield vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Global Medical REIT Dividend Yield account and Price To Sales Ratio. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Global Medical's Dividend Yield and Price To Sales Ratio is -0.66. Overlapping area represents the amount of variation of Dividend Yield that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Global Medical REIT, assuming nothing else is changed. The correlation between historical values of Global Medical's Dividend Yield and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Dividend Yield of Global Medical REIT are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Dividend Yield i.e., Global Medical's Dividend Yield and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.66

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Dividend Yield

Dividend Yield is Global Medical REIT dividend as a percentage of Global Medical stock price. Global Medical REIT dividend yield is a measure of Global Medical stock productivity, which can be interpreted as interest rate earned on an Global Medical investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Global Medical REIT stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Global Medical sales, a figure that is much harder to manipulate than other Global Medical REIT multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Global Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Global Medical REIT current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At present, Global Medical's Enterprise Value Multiple is projected to increase based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 18.9 M, whereas Issuance Of Capital Stock is projected to grow to (71 K).

	2022	2023	2024	2025 (projected)
Total Revenue	137.3M	140.9M	162.1M	170.2M
Depreciation And Amortization	98.8M	59.0M	67.9M	40.7M

Total Revenue Depreciation And Amortization

Global Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Common Stock Shares Outstanding	Net Tangible Assets	Accounts Payable	Retained Earnings Total Equity	Capital Surpluse	Short Long Term Debt Total	Other Liab	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt
Total Assets		-0.29	0.56	1.0	1.0	-0.96	-0.02	0.63	0.99	-0.19	0.99	1.0	0.83	0.99	0.99	0.99	0.97	-0.97	0.99	0.91	0.99	-0.29	0.96	0.98	0.5	0.11
Other Current Liab	-0.29		-0.54	-0.28	-0.3	0.31	0.0	0.14	-0.25	-0.35	-0.26	-0.3	-0.04	-0.25	-0.27	-0.27	-0.34	0.37	-0.26	-0.26	-0.24	0.13	-0.34	-0.28	-0.59	0.08
Total Current Liabilities	0.56	-0.54		0.54	0.55	-0.4	0.16	-0.22	0.48	-0.51	0.48	0.56	0.01	0.48	0.46	0.46	0.41	-0.5	0.48	0.68	0.51	-0.18	0.67	0.53	0.89	0.38
Total Stockholder Equity	1.0	-0.28	0.54		0.98	-0.95	0.02	0.64	0.99	-0.19	0.99	0.98	0.83	0.99	0.99	0.99	0.96	-0.96	0.99	0.9	0.99	-0.26	0.95	0.97	0.48	0.12
Net Debt	1.0	-0.3	0.55	0.98		-0.96	-0.06	0.62	0.98	-0.17	0.98	1.0	0.82	0.98	0.99	0.98	0.97	-0.97	0.98	0.9	0.98	-0.32	0.95	0.99	0.51	0.08
Retained Earnings	-0.96	0.31	-0.4	-0.95	-0.96		0.09	-0.7	-0.97	0.04	-0.97	-0.96	-0.89	-0.97	-0.98	-0.97	-0.98	0.99	-0.97	-0.81	-0.96	0.33	-0.91	-0.95	-0.43	0.1
Cash	-0.02	0.0	0.16	0.02	-0.06	0.09		0.21	-0.03	-0.16	-0.01	-0.04	-0.02	-0.03	-0.05	0.01	-0.1	0.1	-0.01	-0.05	-0.06	0.48	0.01	-0.1	0.17	0.12
Cash And Short Term Investments	0.63	0.14	-0.22	0.64	0.62	-0.7	0.21		0.67	0.21	0.69	0.61	0.94	0.67	0.69	0.71	0.7	-0.61	0.69	0.39	0.63	0.0	0.49	0.6	-0.16	-0.22
Common Stock Total Equity	0.99	-0.25	0.48	0.99	0.98	-0.97	-0.03	0.67		-0.17	1.0	0.98	0.86	1.0	1.0	1.0	0.97	-0.97	1.0	0.86	0.99	-0.31	0.93	0.97	0.45	0.04
Other Current Assets	-0.19	-0.35	-0.51	-0.19	-0.17	0.04	-0.16	0.21	-0.17		-0.16	-0.19	0.14	-0.17	-0.13	-0.14	-0.02	0.1	-0.16	-0.27	-0.22	0.2	-0.26	-0.2	-0.47	-0.25
Other Stockholder Equity	0.99	-0.26	0.48	0.99	0.98	-0.97	-0.01	0.69	1.0	-0.16		0.98	0.87	1.0	1.0	1.0	0.98	-0.97	1.0	0.86	0.99	-0.29	0.93	0.97	0.46	0.02
Total Liab	1.0	-0.3	0.56	0.98	1.0	-0.96	-0.04	0.61	0.98	-0.19	0.98		0.82	0.98	0.99	0.98	0.97	-0.97	0.98	0.9	0.98	-0.31	0.95	0.98	0.52	0.08
Total Current Assets	0.83	-0.04	0.01	0.83	0.82	-0.89	-0.02	0.94	0.86	0.14	0.87	0.82		0.86	0.88	0.88	0.89	-0.83	0.87	0.61	0.83	-0.2	0.7	0.82	0.05	-0.18
Common Stock	0.99	-0.25	0.48	0.99	0.98	-0.97	-0.03	0.67	1.0	-0.17	1.0	0.98	0.86		1.0	1.0	0.97	-0.97	1.0	0.86	0.99	-0.31	0.93	0.97	0.45	0.04
Common Stock Shares Outstanding	0.99	-0.27	0.46	0.99	0.99	-0.98	-0.05	0.69	1.0	-0.13	1.0	0.99	0.88	1.0		1.0	0.99	-0.98	1.0	0.85	0.99	-0.3	0.93	0.97	0.45	0.0
Net Tangible Assets	0.99	-0.27	0.46	0.99	0.98	-0.97	0.01	0.71	1.0	-0.14	1.0	0.98	0.88	1.0	1.0		0.98	-0.97	1.0	0.84	0.99	-0.29	0.93	0.97	0.45	0.0
Accounts Payable	0.97	-0.34	0.41	0.96	0.97	-0.98	-0.1	0.7	0.97	-0.02	0.98	0.97	0.89	0.97	0.99	0.98		-0.98	0.98	0.81	0.97	-0.33	0.9	0.97	0.43	-0.09
Retained Earnings Total Equity	-0.97	0.37	-0.5	-0.96	-0.97	0.99	0.1	-0.61	-0.97	0.1	-0.97	-0.97	-0.83	-0.97	-0.98	-0.97	-0.98		-0.97	-0.84	-0.97	0.34	-0.94	-0.96	-0.53	0.06
Capital Surpluse	0.99	-0.26	0.48	0.99	0.98	-0.97	-0.01	0.69	1.0	-0.16	1.0	0.98	0.87	1.0	1.0	1.0	0.98	-0.97		0.86	0.99	-0.29	0.93	0.97	0.46	0.02
Short Long Term Debt Total	0.91	-0.26	0.68	0.9	0.9	-0.81	-0.05	0.39	0.86	-0.27	0.86	0.9	0.61	0.86	0.85	0.84	0.81	-0.84	0.86		0.87	-0.26	0.94	0.89	0.46	0.46
Other Liab	0.99	-0.24	0.51	0.99	0.98	-0.96	-0.06	0.63	0.99	-0.22	0.99	0.98	0.83	0.99	0.99	0.99	0.97	-0.97	0.99	0.87		-0.34	0.94	0.98	0.5	0.04
Property Plant And Equipment Net	-0.29	0.13	-0.18	-0.26	-0.32	0.33	0.48	0.0	-0.31	0.2	-0.29	-0.31	-0.2	-0.31	-0.3	-0.29	-0.33	0.34	-0.29	-0.26	-0.34		-0.28	-0.45	-0.24	0.16
Non Current Assets Total	0.96	-0.34	0.67	0.95	0.95	-0.91	0.01	0.49	0.93	-0.26	0.93	0.95	0.7	0.93	0.93	0.93	0.9	-0.94	0.93	0.94	0.94	-0.28		0.93	0.59	0.17
Non Currrent Assets Other	0.98	-0.28	0.53	0.97	0.99	-0.95	-0.1	0.6	0.97	-0.2	0.97	0.98	0.82	0.97	0.97	0.97	0.97	-0.96	0.97	0.89	0.98	-0.45	0.93		0.49	0.07
Other Assets	0.5	-0.59	0.89	0.48	0.51	-0.43	0.17	-0.16	0.45	-0.47	0.46	0.52	0.05	0.45	0.45	0.45	0.43	-0.53	0.46	0.46	0.5	-0.24	0.59	0.49		-0.08
Long Term Debt	0.11	0.08	0.38	0.12	0.08	0.1	0.12	-0.22	0.04	-0.25	0.02	0.08	-0.18	0.04	0.0	0.0	-0.09	0.06	0.02	0.46	0.04	0.16	0.17	0.07	-0.08

Click cells to compare fundamentals

Global Medical Account Relationship Matchups

Global Medical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.1B	1.3B	1.4B	1.3B	1.5B	1.5B
Other Current Liab	12.5M	15.7M	(625.1M)	11.7M	10.6M	11.1M
Total Current Liabilities	541.4M	540.6M	666.1M	30.0M	34.5M	32.8M
Total Stockholder Equity	444.8M	622.8M	633.0M	583.6M	671.1M	704.7M
Net Debt	581.1M	564.5M	690.1M	616.8M	709.3M	744.8M
Retained Earnings	(116.8M)	(157.0M)	(198.7M)	(239.0M)	(215.1M)	(204.3M)
Cash	5.5M	7.2M	4.0M	1.3M	1.5M	1.4M
Cash And Short Term Investments	5.5M	7.2M	4.0M	26.4M	30.4M	31.9M
Common Stock Total Equity	44K	49K	65K	66K	75.9K	79.7K
Liabilities And Stockholders Equity	1.1B	1.3B	1.4B	1.3B	1.5B	1.5B
Other Current Assets	(41.5M)	(50.3M)	18.3M	6.1M	5.5M	5.8M
Other Stockholder Equity	504.8M	711.4M	722.0M	722.4M	830.8M	872.3M
Total Liab	643.1M	625.9M	744.2M	661.9M	761.2M	799.2M
Total Current Assets	21.3M	24.9M	30.5M	67.6M	77.8M	81.6M
Common Stock	44K	49K	65K	66K	75.9K	79.7K
Common Stock Shares Outstanding	46.3M	60.6M	65.5M	65.6M	75.4M	79.2M
Net Tangible Assets	313.9M	363.9M	541.9M	552.1M	634.9M	666.7M
Accounts Payable	7.3M	10.3M	13.8M	12.8M	14.7M	15.4M
Retained Earnings Total Equity	(71.4M)	(116.8M)	(157.0M)	(198.7M)	(178.8M)	(169.9M)
Capital Surpluse	433.3M	504.8M	711.4M	722.0M	830.3M	871.8M
Short Long Term Debt Total	604.7M	579.5M	694.1M	618.9M	711.7M	478.8M
Other Liab	11.2M	12.6M	20.4M	17.5M	20.1M	21.1M
Property Plant And Equipment Net	3.6M	3.8M	3.5M	11.0M	9.9M	9.4M
Non Current Assets Total	1.1B	1.2B	1.4B	1.2B	1.4B	783.7M
Non Currrent Assets Other	971.9M	1.1B	1.2B	1.1B	1.3B	1.4B
Other Assets	985.7M	1.1B	1.2B	(1K)	(1.2K)	(1.1K)
Long Term Debt	83.0M	57.2M	57.7M	25.9M	23.3M	22.1M
Net Receivables	5.7M	6.2M	8.2M	33.5M	38.5M	40.5M
Long Term Debt Total	386.2M	83.0M	65.0M	57.7M	66.3M	63.0M
Non Current Liabilities Total	101.8M	85.3M	78.1M	631.9M	726.7M	763.0M
Property Plant And Equipment Gross	3.6M	3.8M	3.5M	11.0M	9.9M	9.4M
Short Long Term Debt	521.6M	514.6M	636.4M	585.3M	673.1M	706.8M
Accumulated Other Comprehensive Income	(18.2M)	(6.6M)	34.7M	25.1M	28.9M	30.3M
Non Current Liabilities Other	14.4M	12.2M	15.0M	9.0M	10.3M	8.1M
Short Term Debt	521.6M	514.6M	636.4M	405K	465.8K	442.5K
Property Plant Equipment	793.0M	1.0B	1.2B	1.3B	1.5B	1.6B
Noncontrolling Interest In Consolidated Entity	30.1M	13.0M	14.8M	16.1M	18.5M	16.1M
Inventory	51.5M	(1.2M)	(34.7M)	(25.1M)	(22.6M)	(21.5M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:

How To Invest In Global

Details

Is Global Stock a good investment?

Details

What is Global Medical's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.43)

Dividend Share

0.84

Earnings Share

(0.02)

Revenue Per Share

2.082

Quarterly Revenue Growth

(0.04)

The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Global Dividend Yield vs Price To Sales Ratio Analysis

Dividend Yield vs Price To Sales Ratio

Dividend Yield vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Dividend Yield

Price To Sales Ratio

Global Medical fundamental ratios Correlations

Global Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Global Medical fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Debt	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Total Liab	+ 1.0	Net Debt
Other Stockholder Equity	+ 1.0	Common Stock Total Equity
Common Stock	+ 1.0	Common Stock Total Equity

Retained Earnings Total Equity	- 0.98	Accounts Payable
Retained Earnings Total Equity	- 0.98	Common Stock Shares Outstanding
Accounts Payable	- 0.98	Retained Earnings
Common Stock Shares Outstanding	- 0.98	Retained Earnings
Other Liab	- 0.97	Retained Earnings Total Equity
Capital Surpluse	- 0.97	Retained Earnings Total Equity